Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
RESEARCH TOOLSreports
Enliven Therapeutics (ELVN) Ownership - Who Owns Enliven Therapeutics?
267 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 20, 2024 | Orbimed Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $22877262 |
| May 20, 2024 | Rishi Gupta Director, >10% Owner | xxxxxxxxxxxxx | $22877262 |
| Feb 16, 2024 | 5am Partners Vi, Llc >10% Owner | xxxxxxxxxxxxx | $12292500 |
| Feb 02, 2024 | 5am Partners Vi, Llc >10% Owner | xxxxxxxxxxxxx | $7500000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $167280 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $443109 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $2019912 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $56337216 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,202,798 | Institution | 6.81% | 70,493,584 | |
| 2,206,099 | Institution | 4.69% | 48,556,239 | |
| 2,122,465 | Institution | 4.51% | 46,715,455 | |
| 2,121,197 | Institution | 4.51% | 46,687,546 | |
| 1,760,443 | Institution | 3.74% | 38,747,350 | |
| 1,073,638 | Institution | 2.28% | 23,630,772 | |
| 957,309 | Institution | 2.04% | 21,070,371 | |
| 956,113 | Institution | 2.03% | 21,044,047 | |
| 425,008 | Institution | 0.90% | 9,354,426 | |
| 395,686 | Institution | 0.84% | 8,709,049 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,121,197 | Institution | 4.51% | 46,687,546 | |
| 1,073,638 | Institution | 2.28% | 23,630,772 | |
| 957,309 | Institution | 2.04% | 21,070,371 | |
| 956,113 | Institution | 2.03% | 21,044,047 | |
| 425,008 | Institution | 0.90% | 9,354,426 | |
| 365,435 | Institution | 0.78% | 8,043,224 | |
| 252,158 | Institution | 0.54% | 5,549,998 | |
| 121,040 | Institution | 0.26% | 2,664,090 | |
| 103,166 | Institution | 0.22% | 2,270,684 | |
| 102,977 | Institution | 0.22% | 2,266,524 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,446,772 | Institution | 3.08% | 25,626,596 | |
| 933,754 | Institution | 1.99% | 20,551,926 | |
| 530,656 | Institution | 1.13% | 9,287,665 | |
| 296,645 | Institution | 0.63% | 6,529,156 | |
| 198,487 | Institution | 0.42% | 4,368,699 | |
| 131,048 | Institution | 0.28% | 3,062,592 | |
| 118,017 | Institution | 0.25% | 2,667,184 | |
| 79,524 | Institution | 0.17% | 1,750,323 | |
| 63,368 | Institution | 0.13% | 1,480,910 | |
| 66,057 | Institution | 0.14% | 1,453,915 |
FAQ
Who Owns Enliven Therapeutics (ELVN)?
Currently, no data Available
What percentage of Enliven Therapeutics (ELVN) stock is held by institutional investors?
Currently, no data Available
What percentage of Enliven Therapeutics (ELVN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Enliven Therapeutics (ELVN)?
Peter Harwin owns the most shares of Enliven Therapeutics (ELVN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.